The 27 analysts offering 12-month price forecasts for Biogen Inc have a median target of 330.00, with a high estimate of 420.00 and a low estimate of 245.00. The median estimate represents a +4.31% increase from the last price of 316.36.
The current consensus among 32 polled investment analysts is to Hold stock in Biogen Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $7.76
Reporting Date Apr 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.